Top Markets
#1 Nesa Nesa +868.18%
#2 Black Phoenix Black Phoenix +855.17%
#3 QuantixAI QuantixAI +102.94%
#4 MetaDAO MetaDAO +29.39%
#5 Ontology Gas Ontology Gas +27.37%
#6 Wrapped STX (Velar) Wrapped STX (Velar) +23.73%
#7 Bedrock Bedrock +18.94%
#8 peaq peaq +17.65%
#9 Stacks Stacks +14.76%
#10 Humanity Humanity +14.73%
Coin of the day
Nesa Nesa
Settings
Language
ENGLISH
Currency
USD
Theme
Zhangzhou Pientzehuang Pharmaceutical., Ltd Zhangzhou Pientzehuang Pharmaceutical., Ltd

Zhangzhou Pientzehuang Pharmaceutical., Ltd

600436
Rank in Stocks #1994
Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. is a Chinese company,... Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. is a Chinese company, headquartered in Zhangzhou, that specializes in the production and distribution of traditional Chinese medicines. Its offerings, predominantly sold under the renowned Pien Tze Huang brand, reach consumers both domestically within China and across international markets. Beyond its core pharmaceutical products, the company's expansive portfolio encompasses health and wellness items, beauty care products, household chemical goods, a variety of medical devices, and nutritional supplements. The firm operates as a subsidiary of Zhangzhou Jiulongjiang Group Co., Ltd.
Share Price
$18.28
Market Cap
$11.03B
Change (1 day)
1.92%
Change (1 year)
-38.91%
Country
CN
Trade Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436)

Category

Healthcare
Revenue for Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436)
Revenue in Aug 2026 TTM: 0
According to Zhangzhou Pientzehuang Pharmaceutical., Ltd latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Zhangzhou Pientzehuang Pharmaceutical., Ltd from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 $79.67B -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 $97.93B -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 $64.39B -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 $77.52B -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 $66.40B -
US